AstraZeneca
and portfolio evolution enables long term sustainable growth key i medicines grew in market leadership within first year of launch substantial growth opportunity remains growth of brands more than offset generic impact on older medicines market share expansion globally within growing class growth strengthens foundation for next gen | AstraZeneca
Company
Deck Type
Deck date
November 2023
Slide
23 of 45
Related slides by other companies
Investor Conference
January 2024
Investor Presentation
February 2024
Investor Presentation
May 2022
Results
April 2022
Other recent decks by AstraZeneca
Results
February 2024
Investor Conference
January 2024
Results
July 2023
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io